Cases 1 - 10 of 346
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-2019
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-2002
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC., AMGEN USA, INC. and others
In re: Sensipar Cinacalcet Hydrochloride Tablets
as 24-1911
Not Yet Classified:
In re: SENSIPAR CINACALCET HYDROCHLORIDE TABLETS ANTITRUST LITIGATION
Plaintiff:
CESAR CASTILLO LLC and KPH HEALTHCARE SERVICES INC, AKA Kinney Drugs Inc
Defendant:
AMGEN INC, TEVA PHARMACEUTICALS USA INC, WATSON LABORATORIES INC and others
AMGEN INC. et al v. CELLTRION, INC. et al
as 1:2024cv06497
Plaintiff:
AMGEN INC. and AMGEN MANUFACTURING LIMITED LLC
Defendant:
CELLTRION, INC. and CELLTRION USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 1:2024cv00039
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Amgen, Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Amgen Inc. v. Colorado Prescription Drug Affordability Review Board et al
as 1:2024cv00810
Plaintiff:
Amgen Inc., Immunex Corporation and Amgen Manufacturing, Limited
Defendant:
Colorado Prescription Drug Affordability Review Board, Gail Mizner, Sami Diab and others
Cause Of Action: 28 U.S.C. § 2403 - Constitutionality of State Statute(s)
Warner v. Amgen Inc. et al
as 1:2024cv10632
Plaintiff:
Elissa M Warner
Defendant:
Amgen Inc., Amgen USA, Inc., NOVARTIS INSTITUTES for BIOMEDICAL RESEARCH, INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Notice of Removal
In re: Sandoz, Inc.
as 1:2024cv00059
Petitioner:
Amgen, Inc.
Respondent:
Sandoz, Inc.
Cause Of Action: 28 U.S.C. § 1782 Letter rogatory - appointment
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 2:2024cv00264
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Amgen, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
